Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Beam Therapeutics Inc
About BEAM
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302 and BEAM-301. BEAM-101 is a patient-specific, autologous hematopoietic stem cell (HSC), investigational therapy. ESCAPE is a potentially non-genotoxic approach to HSC transplantation. BEAM-302 is a liver-targeting lipid nanoparticle formulation of base editing reagents designed to offer a one-time treatment to correct the E342K point mutation (PiZZ genotype).
Find out what a historical investment in Beam Therapeutics Inc would be worth today using our BEAM stock calculator.
Market Capitalisation
$2.85B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.33M
High today
$29.14
Low today
$27.63
Open price
$27.70
52-week high
$36.44
52-week low
$15.35
Ready to start your investing journey with Stake?
Open an accountHow do I buy BEAM shares in Australia?
Buying BEAM shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Beam Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BEAM
What is the ticker symbol of Beam Therapeutics Inc?
The ticker symbol for Beam Therapeutics Inc is BEAM.
How much is one share of BEAM?
One share of BEAM is valued at $28.74 as of 23 May 2026.
What is the market capitalisation of Beam Therapeutics Inc BEAM?
As of 23 May 2026 Beam Therapeutics Inc has a market cap of $2.85B.
What is the 52-week high for Beam Therapeutics Inc stock?
The Beam Therapeutics Inc 52-week high stock price is $36.44.
What is the 52-week low for Beam Therapeutics Inc stock?
The Beam Therapeutics Inc 52-week low stock price is $15.35.
Can I buy BEAM shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BEAM shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BEAM on Stake
- Buy BEAM from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of BEAM from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
BEAM related stocks